Table 4.
Effect of curcumin supplementation on total leukocytes.
| Cell type | Mean ± SD at time point | P-value | |
|---|---|---|---|
| T0 | T3 | ||
| % CD45+ cells | 99.47 ± 0.3502 | 97.9 ± 3.659 | 0.4099 |
| % HLA-ABC by CD45+ | 99.97 ± 0.05164 | 99.92 ± 0.2041 | 1.000 |
| % HLA-DR by CD45+ | 47.22 ± 16.88 | 41.03 ± 15.74 | 0.0313 |
| % HLA-E by CD45+ | 4.85 ± 6.392 | 3.467 ± 5.411 | 0.625 |
| % HLA-G by CD45+ | 5.967 ± 4.978 | 4.9 ± 4.626 | 0.4375 |
| MFI HLA-ABC by CD45+ | 29719 ± 6539 | 25681 ± 4199 | 0.0313 |
| MFI HLA-DR by CD45+ | 6751 ± 2778 | 5759 ± 1745 | 0.0625 |
| MFI HLA-E by CD45+ | 8008 ± 754.3 | 7741 ± 635.4 | 0.4375 |
| MFI HLA-G by CD45+ | 5759 ± 3365 | 6658 ± 4823 | 0.4375 |
This table depicts the results of the flow cytometric analysis of total leukocytes (CD45+ cells) and their expression of HLA molecules (expressed both as percentage and MFI). Data are expressed as mean ± standard deviations. P-values were calculated using the nonparametric Wilcoxon matched-pairs test with Prism software. T0, baseline; T3, day 14 of treatment.